---
figid: PMC9691330__OMCL2022-4661519.005
pmcid: PMC9691330
image_filename: OMCL2022-4661519.005.jpg
figure_link: /pmc/articles/PMC9691330/figure/fig5/
number: Figure 5
figure_title: ''
caption: 'BHF177 activates the GABAB receptor to attenuate DNP symptoms by inactivating
  the NR2B-PKC-CaMKII-ERK-CREB pathway. DNP rats were injected with BHF177+PMA, BHF177+CaCl2,
  and BHF177+EGF (n = 6/group). (a) The PWT and PWL of DNP rats after different treatments.
  (b) The mRNA expression of PKC or CaMKII in DNP rats determined using RT-qPCR. (c)
  The protein expression of GABAB receptors, NR2B, PKC, CaMKII, p-ERK1/2, or p-CREB
  in DNP rats determined using immunoblotting. n = 6. âˆ—p < 0.05 vs. DNP rats #p <
  0.05 vs. DNP rats treated with BHF177.'
article_title: BHF177 Suppresses Diabetic Neuropathic Pain by Blocking PKC/CaMKII/ERK1/2/CREB
  Signaling Pathway through Activating GABAB Receptor.
citation: Boyu Liu, et al. Oxid Med Cell Longev. 2022;2022:4661519.
year: '2022'

doi: 10.1155/2022/4661519
journal_title: Oxidative Medicine and Cellular Longevity
journal_nlm_ta: Oxid Med Cell Longev
publisher_name: Hindawi

keywords:
---
